Written and medically reviewed by: Assoc. Prof. Cengiz Dibekoğlu, MD, General SurgeryLast updated:
GIST and Neuroendocrine Tumors — GIST & NET Treatment
Resection and TKIs for GIST; grade-tailored surgery, PRRT, and systemic options for NETs.
GIST care pairs surgery with neoadjuvant or adjuvant imatinib in mutation-appropriate higher-risk cases and uses later TKIs at progression. NET care scales from active surveillance of tiny indolent lesions to multimodal therapy for progressive or metastatic disease, always filtered by grade. Cross-applying colorectal adenocarcinoma pathways is a common and costly error. These tumors follow sarcoma or neuroendocrine rules, not generic adenocarcinoma pathways.
Educational schematic. Some structures may be simplified or emphasized for clarity; not an exact anatomical depiction.
© Cengiz Dibekoğlu — illustrative; not for unauthorized use
Figure summary
Labeled on this figure: Multimodal plan · Surgery · Systemic therapy.
Figure labels (English)
- Multimodal plan
- Surgery
- Systemic therapy
Who may be a candidate?
- International patients preparing a structured second-opinion visit
- Patients comparing observation, medical care, and procedural options
Possible advantages
- Supports informed consent with alternatives and recovery themes
- Highlights red flags that should trigger urgent contact
Limits & realistic expectations
- Cannot replace examination, imaging, or pathology
- Local protocols and tumor-board decisions may refine timing
- Outcomes vary with anatomy, stage, and comorbidity
Step-by-step overview
- 1
Clarify the clinical question
What diagnosis is being confirmed and what decision follows?
- 2
Choose first-line tests
Start with the test that answers the leading question safely.
- 3
Stage if needed
Add imaging or endoscopy when results would change management.
- 4
Name limitations
No test replaces exam; false reassurance is a risk.
- 5
Link to next step
Diagnosis should point to observation, medical care, or procedure.
Key points
- Key note inside
Technique vs indication
A named technique is only useful when anatomy and disease biology fit. Conversion to another approach can be a safety decision, not a failure. Discuss timing, alternatives, and follow-up with your surgical team before you finalize a plan.
- Key note inside
Important
This page is for education. It is not medical advice and does not replace a visit with your physician.
Frequently asked questions
Is surgery always required for GIST/NET?
Not always. Selected small low-risk gastric GISTs may be observed; many NETs are treated by grade and stage with surgery, surveillance, or systemic options.
How are options chosen?
Extent of disease, symptoms, fitness, and evidence-based alternatives are weighed together — often in a multidisciplinary setting for cancer.
What should I ask before consent?
Benefits, risks, alternatives, expected recovery, and what happens if pathology or imaging changes the plan.
Can I get a second opinion?
Yes. Bring complete imaging and pathology; tumor-board review can be requested when appropriate.
More chapters in this hub
Appointment / info
This page is for education. It is not medical advice and does not replace a visit with your physician.
Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · Last medically reviewed: August 2026 · English patient-education chapter.